Kirk Habegger, PhD: - Assistant Professor in the Department of Medicine, Division of Endocrinology, Diabetes & Metabolism. Dr. Habegger joined the faculty of UAB in 2013, coming from the University of Cincinnati, Metabolic Diseases Institute. Throughout his training, he has acquired a diverse background in energy metabolism research, endocrinology, biochemistry and integrative physiology.
Both developed and developing countries have seen increased rates of obesity over the last 30 years that has been paralleled by an unprecendented increase in the incidence of metabolic disturbances such as hypertension, dyslipidemia, and type-2 diabetes. A targeted search for the molecular underpinnings of the onset and progression of these disturbances is needed for the development of potential treatments. Dr. Habegger's work aims to discover and dissect neuroendocrine and peripheral signaling pathways that regulate energy, glucose and lipid metabolism. Many of the projects in his group investigate novel pharmacological therapies against diabetes and obesity in rodent models. Current projects in Dr. Habegger's group focus on 1) the non-cannonical aspects of glucagon biology including its role in the adaptive response to exercise and 2) CNS integration of nutrient sensing. Habegger@uab.edu